Filiatreau Lindsey M, Ebasone Peter Vanes, Dzudie Anastase, Wainberg Milton, Yotebieng Marcel, Anastos Kathryn, Parcesepe Angela M
School of Medicine, Division of Infectious Diseases, Washington University in St. Louis, St. Louis, MO, USA.
Clinical Research Education Networking and Consultancy, Yaoundé, Cameroon.
AIDS Behav. 2024 Sep;28(9):2950-2960. doi: 10.1007/s10461-024-04375-2. Epub 2024 May 20.
Mental health-related stigma is a prominent barrier to improved mental health outcomes globally and may be particularly harmful to populations with other stigmatized identities. We aimed to understand intersectional depression- and HIV-related stigma among people with HIV (PWH) entering HIV care in Cameroon. Using baseline data from a cohort of PWH entering HIV care in Cameroon between 2019 and 2020, we characterized depression- and HIV-related stigma in the population overall and by sociodemographic sub-group. We also explored substantively meaningful variation in stigma endorsement by depressive symptom severity (Patient Health Questionnaire-9 [PHQ-9]) and causal attribution of depression. Among those with elevated depressive symptoms (PHQ-9 scores > 4), we estimated the association between stigma type and depressive symptom severity using binomial regression. Among 398 participants, 49% endorsed low HIV- and depression-related stigma (N = 195), 10% endorsed high HIV- and depression-related stigma (N = 38), 29% endorsed high depression-related stigma only (N = 116), and 12% endorsed high HIV-related stigma only (N = 49). Respondents with and without heightened depressive symptoms commonly believed depressive symptoms were caused by HIV (N = 140; 32.9%). Among those with elevated depressive symptoms, the prevalence of moderate to severe symptoms was higher among those endorsing high HIV-related stigma only (prevalence ratio 1.55; 95% confidence interval: 1.01, 2.37) compared to those reporting low HIV- and depression-related stigma. HIV- and depression-related stigma are both common among PWH entering HIV care in Cameroon. The consistent association between HIV-related stigma and poor psychosocial well-being among people with HIV necessitates the urgent scale-up of evidence-based HIV-related stigma interventions specifically.
与心理健康相关的污名是全球改善心理健康结果的一个突出障碍,对具有其他被污名化身份的人群可能尤其有害。我们旨在了解喀麦隆开始接受艾滋病护理的艾滋病毒感染者(PWH)中与抑郁症和艾滋病毒相关的交叉污名。利用2019年至2020年期间喀麦隆开始接受艾滋病护理的一组艾滋病毒感染者的基线数据,我们描述了总体人群以及按社会人口亚组划分的与抑郁症和艾滋病毒相关的污名情况。我们还探讨了抑郁症状严重程度(患者健康问卷-9[PHQ-9])和抑郁症的因果归因在污名认同方面具有实质意义的差异。在抑郁症状加重的人群(PHQ-9评分>4)中,我们使用二项式回归估计了污名类型与抑郁症状严重程度之间的关联。在398名参与者中,49%的人认同与艾滋病毒和抑郁症相关的低污名(N = 195),10%的人认同与艾滋病毒和抑郁症相关的高污名(N = 38),29%的人仅认同与抑郁症相关的高污名(N = 116),12%的人仅认同与艾滋病毒相关的高污名(N = 49)。有和没有抑郁症状加重的受访者普遍认为抑郁症状是由艾滋病毒引起的(N = 140;32.9%)。在抑郁症状加重的人群中,仅认同与艾滋病毒相关的高污名的人群中中度至重度症状的患病率高于那些报告与艾滋病毒和抑郁症相关的低污名的人群(患病率比值1.55;95%置信区间:1.01,2.37)。在喀麦隆开始接受艾滋病护理的艾滋病毒感染者中,与艾滋病毒和抑郁症相关的污名都很常见。艾滋病毒相关污名与艾滋病毒感染者心理社会福祉不佳之间的一致关联尤其需要紧急扩大基于证据的与艾滋病毒相关的污名干预措施。